daunorubicin has been researched along with peplomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamura, Y; Kiyota, H; Kosuda, S; Saito, K; Tadokoro, M | 1 |
| Umezawa, H | 1 |
2 other study(ies) available for daunorubicin and peplomycin
| Article | Year |
|---|---|
[Malignant lymphoma differentiated to plasma cell of the testis: report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Humans; Lymphoma; Male; Orchiectomy; Peplomycin; Plasma Cells; Testicular Neoplasms; Vinblastine | 1987 |
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Lung; Lung Neoplasms; Mice; Molecular Weight; Naphthacenes; Peplomycin; Structure-Activity Relationship | 1982 |